CARLSON CAPITAL L P 13D/13G Filings for Albireo Pharma, Inc. (ALBO)

CARLSON CAPITAL L P 13D and 13G filings for Albireo Pharma, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2023-02-24
5:24 pm
Purchase
2023-02-1713GAlbireo Pharma, Inc.
ALBO
CARLSON CAPITAL L P1,075,000
5.200%
1,075,000increase
(New Position)
Filing